临床医学工程2015，Vol.22Issue(11)：1459-1460,2.DOI:10.3969/j.issn.1674-4659.2015.11.1459
新活素治疗心肾综合征顽固性心力衰竭的疗效观察
Observation on the Therapeutic Effect of Xinhuosu for the Treatment of Patients with Refractory Heart Failure Complicated with Cardiorenal Syndrome
洪浩敏 1陈松深 1邱浩强1
作者信息
- 1. 南方医科大学附属普宁华侨医院神经内科, 广东普宁 515300
- 折叠
摘要
Abstract
Objective To explore the clinical effect of Xinhuosu for the treatment of patients with refractory heart failure complicated with cardiorenal syndrome. Methods 92 patients with refractory heart failure complicated with cardiorenal syndrome were divided into two groups equally. The control group was given routine therapy, while the research group was given Xinhuosu therapy on the basis of routine therapy. The clinical manifestations and improvement situations of cardiorenal function after therapy were compared. Results The clinical effective rate of research group was 95.65%, significantly higher than 82.61% of control group (P <0.05). After therapy, the level of NT-pro-BNP decreased significantly in both groups (P<0.05), and the research group decreased more significantly than the control group (P<0.05). The level of Cr decreased significantly in both groups (P<0.05), and the declines of two groups had no statistical difference (P>0.05). The level of LVEF increased significantly in both groups (P<0.05), and the research group increased more significantly than the control group (P<0.05). No drug allergy, hypotension, or other serious adverse reaction was found in both groups during therapy. Conclusions Xinhuosu has significant efficacy and safety for the treatment of patients with refractory heart failure complicated with cardiorenal syndrome.关键词
顽固性心力衰竭/心肾综合征/新活素Key words
Refractory heart failure/Cardiorenal syndrome/Xinhuosu分类
医药卫生引用本文复制引用
洪浩敏,陈松深,邱浩强..新活素治疗心肾综合征顽固性心力衰竭的疗效观察[J].临床医学工程,2015,22(11):1459-1460,2.
